Pharmaceuticals India

India Family Planning Products Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

India Family Planning Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

India · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $357.2 Mn Placeholder estimate
Estimate 2025 $386.8 Mn 1.9% of the global market
Projected 2034 $792.8 Mn 105% Adds $406.0 Mn over 9 forecast years
CAGR 2025–2034 8.3% Faster than 19% of 180 Pharmaceuticals markets here
Key players 5
  • India is 1.95% of the global market.
  • In APAC, the largest is China at $1.40 Bn.
  • Fastest growing: India (this report) at 8.3% a year.
  • India ranks 3rd of 10 by size in APAC.

Market size projection

India

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$406.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Family Planning Products Market market size by year, India
YearMarket sizeChange that yearSince 2025
2024 (estimate) $357.2 Mn — —
2025 (base) $386.8 Mn +$29.6 Mn —
2026 (forecast) $418.9 Mn +$32.1 Mn +8.3%
2027 (forecast) $453.7 Mn +$34.8 Mn +17.3%
2028 (forecast) $491.4 Mn +$37.7 Mn +27%
2029 (forecast) $532.1 Mn +$40.8 Mn +37.6%
2030 (forecast) $576.3 Mn +$44.2 Mn +49%
2031 (forecast) $624.1 Mn +$47.8 Mn +61.4%
2032 (forecast) $675.9 Mn +$51.8 Mn +74.7%
2033 (forecast) $732.0 Mn +$56.1 Mn +89.2%
2034 (forecast) $792.8 Mn +$60.8 Mn +105%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

India Family Planning Products Market Analysis at a glance
Market size, 2025$386.8 Mn placeholder estimate
Forecast, 2034$792.8 Mn placeholder estimate
Growth (CAGR), 2025–20348.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and channel (see all)
Key playersBayer AG, Organon, Pfizer Inc., Mylan N.V., DKT International (see all)
Regulator in IndiaCDSCOSource: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The India Family Planning Products Market Analysis Executive Summary

Family planning products help people choose if and when to have children, including pills, implants, injectables and IUDs.

Key segments of the family Planning Products market include product (Implants, Injectables and Oral Pills) and channel (Public Sector, Private Sector and NGOs).

Bar chart: India Family Planning Products market size, 2024–2034, placeholder estimates. $357.2 Mn in 2024, $386.8 Mn in 2025 and $792.8 Mn in 2034, 8.3% CAGR.
India Family Planning Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

India Family Planning Products Market Dynamics

Market Growth Drivers

Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the family Planning Products market.

Opportunity

Digital tools for community health, local manufacturing and public-private partnerships give the family Planning Products market room to grow.

Market Restraints

Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the family Planning Products market.

Competitive Landscape for Family Planning Products Market in India

The family Planning Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Family Planning Products Market in India

Family Planning Products in India: rules, payment and health figures

New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India.⁠[1] Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year.⁠[2] Contraception use: 67% of married women 15–49 in 2021, the latest World Bank figure for India.⁠[3]

[1] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[2] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[3] World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 20 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for family Planning Products. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in India.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Family Planning Products right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Family Planning Products in context

India compared

  • Contraception use: 67% of married women 15–49 (2021). 6th highest of the 16 countries we cover in APAC.[1]
  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 12th highest of the 17 countries we cover in APAC.[2]
  • Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 13th highest of the 17 countries we cover in APAC.[3]

[1] World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Family Planning Products market in India?
Placeholder estimate: about $386.8 Mn in 2025, rising to about $792.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Family Planning Products market in India growing?
Placeholder estimate: about 8.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Family Planning Products market report cover?
The report splits the market by product (Implants, Injectables, Oral Pills, IUDs and more) and channel (Public Sector, Private Sector, NGOs).
Who are the key players in the Family Planning Products market?
Key players include Bayer AG, Organon, Pfizer Inc., Mylan N.V. and DKT International.
What is driving the Family Planning Products market?
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the family Planning Products market.
Who regulates Family Planning Products in India?
New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India. Source: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
How is healthcare paid for in India?
Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year. Source: National Health Authority (PM-JAY). Checked 14 Nov 2026.
What does World Bank report for India?
Contraception use: 67% of married women 15–49 in 2021, the latest World Bank figure. Source: World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 20 Nov 2026.
How many people in India are 65 or older?
7.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 19 Nov 2026.
How much research is published on Family Planning Products?
PubMed lists 5,955 papers on Family Planning Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in India

See all

Related on contraception and women's health

See the topic